Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Rifaximin on Gut Microbiota and Emotion
NCT05587036Phase 3Recruiting
- Sponsor
- UZ Leuven
- Start
- Feb 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin, sponsored by UZ Leuven. Started Feb 2023; status: recruiting.
02
Drugs
rifaximin
Beyond the preview
Go deeper on NCT05587036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05587036.